Back

Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Cardiac amyloidosis (3) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Tsilakis

Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Discussant - Cardiac amyloidosis (3)
Presentation thumbnail
Evaluating diagnostic scoring systems for early detection of transthyretin amyloidosis in patients with HFpEF and left ventricular hypertrophy
Doctor D. Faro (Catania, IT)
Abstract Video
Presentation thumbnail
Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.
Doctor M. Dicorato (Bari, IT)
Abstract Video
Presentation thumbnail
Detection of arrhythmias in patients with transthyretin cardiac amyloidosis
Doctor I. Simkova (Olomouc, CZ)
Abstract
Presentation thumbnail
Deep screening unveils hidden cardiac amyloidosis: carpal tunnel syndrome as a gateway to early transthyretin cardiac amyloidosis diagnosis
Doctor S. Yoshida (Kanazawa, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Cardiac amyloidosis (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources